Dr. merit cudkowicz, renowned als expert at massachusetts general hospital (mgh), joins klotho neurosciences' scientific advisory board

New york, dec. 09, 2024 (globe newswire) -- klotho neurosciences, inc. (nasdaq: klto), a specialty biotechnology company focused on developing cell and gene therapies for amyotrophic lateral sclerosis (als), alzheimer's and parkinson's disease is proud to announce the appointment of dr. merit cudkowicz, md, msc, to its scientific advisory board (sab). dr. cudkowicz is the chair of neurology at mgh, director of the sean m.
KLTO Ratings Summary
KLTO Quant Ranking